Drug Development And Industrial Pharmacy

Drug Development And Industrial Pharmacy

药物开发和工业药学

  • 4区 中科院分区
  • Q3 JCR分区

期刊简介

《Drug Development And Industrial Pharmacy》是由Informa Healthcare出版社于1974年创办的英文国际期刊(ISSN: 0363-9045,E-ISSN: 1520-5762),该期刊长期致力于药物化学领域的创新研究,主要研究方向为医学-药学。作为SCIE收录期刊(JCR分区 Q3,中科院 4区),本刊采用OA未开放获取模式(OA占比0.0076...%),以发表药物化学领域等方向的原创性研究为核心(研究类文章占比97.59%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在83篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Drug Development And Industrial Pharmacy审稿周期约为 约3.0个月 。该刊近年未被列入国际预警名单,年发文量约83篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 83 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
CHEMISTRY, MEDICINAL 药物化学 PHARMACOLOGY & PHARMACY 药学
4区 4区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
CHEMISTRY, MEDICINAL 药物化学 PHARMACOLOGY & PHARMACY 药学
4区 4区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:CHEMISTRY, MEDICINAL SCIE Q3 50 / 72

31.3%

学科:PHARMACOLOGY & PHARMACY SCIE Q3 188 / 354

47%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CHEMISTRY, MEDICINAL SCIE Q2 34 / 72

53.47%

学科:PHARMACOLOGY & PHARMACY SCIE Q2 130 / 354

63.42%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:6.8 SJR:0.475 SNIP:0.684
学科类别 分区 排名 百分位
大类:Pharmacology, Toxicology and Pharmaceutics 小类:Pharmaceutical Science Q1 44 / 183

76%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Organic Chemistry Q2 54 / 211

74%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Pharmacology Q2 96 / 313

69%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Drug Discovery Q2 49 / 157

69%

期刊发文

  • A comparative study of consistency between Paeonia rubra hort traditional decoction and dispensing granule decoctions from different sources

    Author: Ma, Lijie; Zhang, Huijie; Xu, Manwen; Feng, Wenhao; Shi, Junhan; Wang, Yanli; Zhang, Lu; Gui, Xinjing; Wang, Qingxiao; Wang, Haibo; Yao, Jing; Liu, Ruixin

    Journal: DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY. 2023; Vol. 48, Issue 12, pp. 708-716. DOI: 10.1080/03639045.2022.2161560

  • In vivo and in vitro evaluation of pulmonary administration of itraconazole nanostructured lipid carriers for pulmonary aspergillosis

    Author: Wang, Yanming; Chenghao, Zhang; Wu, Zhaoli; Cui, Xinran; Ren, Jinmei; Tang, Jingling

    Journal: DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY. 2023; Vol. 49, Issue 2, pp. 232-239. DOI: 10.1080/03639045.2023.2200533

  • Enhancement of oral bioavailability and anti-colitis effect of luteolin-loaded polymer micelles with RA (rosmarinic acid)-SS-mPEG as carrier

    Author: Lu, Zhaomin; Liu, Juan; Zhao, Liangjian; Wang, Chenli; Shi, Feng; Li, Zhengqi; Liu, Xuesong; Miao, Zhiwei

    Journal: DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY. 2023; Vol. 49, Issue 1, pp. 17-29. DOI: 10.1080/03639045.2023.2175850

  • Carboxymethyl starch as a solid dispersion carrier to enhance the dissolution and bioavailability of piperine and 18 beta-glycyrrhetinic acid

    Author: Shi, Fanli; Li, Ruilong; Wang, Wenjing; Yu, Xiangyu; Zhu, Fenxia; Huang, Yiping; Wang, Jing; Zhang, Zhenhai

    Journal: DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY. 2023; Vol. 49, Issue 1, pp. 30-41. DOI: 10.1080/03639045.2023.2182120

  • Study on co-delivery of pemetrexed disodium and Bcl-2 siRNA by poly-gamma-glutamic acid-modified cationic liposomes for the inhibition of NSCLC

    Author: Huang, Xiaoyu; Song, Ruonan; Wang, Xiao; He, Kongfang; Shan, Rumeng; Xie, Fei; Huang, Guihua

    Journal: DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY. 2023; Vol. 49, Issue 1, pp. 62-74. DOI: 10.1080/03639045.2023.2182125

  • Study on the taste-masking effect and mechanism of Acesulfame K on berberine hydrochloride

    Author: Li, Haiyang; Fan, Xuehua; Wu, Xiangxiang; Yue, Yousong; Li, Chenxu; Gui, Xinjing; Wang, Yanli; Yao, Jing; Wang, Junming; Zhang, Lu; Li, Xuelin; Shi, Junhan; Liu, Ruixin

    Journal: DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY. 2023; Vol. 49, Issue 1, pp. 92-102. DOI: 10.1080/03639045.2023.2183713

  • Preparation and evaluation in vitro and in vivo of pristinamycin enteric-coated granules based on albumin nanoparticles

    Author: Shan, Wanxin; Peng, Fang; Shen, Qi; Zhang, Jun

    Journal: DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY. 2023; Vol. 49, Issue 1, pp. 84-91. DOI: 10.1080/03639045.2023.2182602

  • Ginsenoside Rg3 liposomes regulate tumor microenvironment for the treatment of triple negative breast cancer

    Author: Miao, Linan; Ma, Hao; Dong, Tingjun; Zhao, Chengcheng; Gao, Tingyu; Wu, Tianyi; Xu, Huan; Zhang, Jing

    Journal: DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY. 2023; Vol. 49, Issue 1, pp. 139-148. DOI: 10.1080/03639045.2023.2188078